GPT and Hepatic fibrosis: While serum ALT and AST levels were unaffected, quantification of the Sirius Red area fraction and hepatic hydroxyproline content revealed a significant reduction of liver fibrosis, upon pharmacological treatment with the GPR84 antagonist (CpdA) (Figure 5C–E).